AU2002236065A1 - Papillomavirus vaccines - Google Patents

Papillomavirus vaccines

Info

Publication number
AU2002236065A1
AU2002236065A1 AU2002236065A AU2002236065A AU2002236065A1 AU 2002236065 A1 AU2002236065 A1 AU 2002236065A1 AU 2002236065 A AU2002236065 A AU 2002236065A AU 2002236065 A AU2002236065 A AU 2002236065A AU 2002236065 A1 AU2002236065 A1 AU 2002236065A1
Authority
AU
Australia
Prior art keywords
papillomavirus vaccines
papillomavirus
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002236065A
Inventor
Julian Kingdon Hickling
Terry O'neill
Rienk Offringa
Sjoerd Van Der Burg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xenova Research Ltd
Leids Universitair Medisch Centrum LUMC
Original Assignee
Xenova Research Ltd
Leids Universitair Medisch Centrum LUMC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenova Research Ltd, Leids Universitair Medisch Centrum LUMC filed Critical Xenova Research Ltd
Publication of AU2002236065A1 publication Critical patent/AU2002236065A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
AU2002236065A 2001-03-07 2002-03-07 Papillomavirus vaccines Abandoned AU2002236065A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0105606A GB0105606D0 (en) 2001-03-07 2001-03-07 Immunogens and vaccines and their preparation and use
GB0105606.8 2001-03-07
PCT/GB2002/000975 WO2002070004A2 (en) 2001-03-07 2002-03-07 Papillomavirus vaccines

Publications (1)

Publication Number Publication Date
AU2002236065A1 true AU2002236065A1 (en) 2002-09-19

Family

ID=9910150

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002236065A Abandoned AU2002236065A1 (en) 2001-03-07 2002-03-07 Papillomavirus vaccines

Country Status (6)

Country Link
EP (1) EP1399182A2 (en)
JP (1) JP2004522789A (en)
AU (1) AU2002236065A1 (en)
BR (1) BR0207899A (en)
GB (1) GB0105606D0 (en)
WO (1) WO2002070004A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2606092A1 (en) * 2005-04-26 2006-11-02 Glaxosmithkline Biologicals S.A. Vaccine
ES2363247T3 (en) * 2005-04-27 2011-07-28 Leiden University Medical Center TREATMENT FOR ANOGENITAL INTRAEPITELIAL NEOPLASIAS Induced by HPV.
EP2199301A1 (en) 2008-12-19 2010-06-23 DKFZ Deutsches Krebsforschungszentrum Immunogenic polypeptides comprising a scaffold polypeptide and a L2 polypeptide or fragment thereof
WO2017211886A1 (en) 2016-06-07 2017-12-14 Deutsches Krebsforschungszentrum Improvement of hpv l2 peptide immunogenicity
US20200397892A1 (en) * 2018-02-22 2020-12-24 Turnstone Limited Partnership Oncolytic viruses as adjuvants

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9105383D0 (en) * 1991-03-14 1991-05-01 Immunology Ltd An immunotherapeutic for cervical cancer
JP3958360B2 (en) * 1995-02-24 2007-08-15 キャンタブ ファーマシューティカルズ リサーチ リミティド Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation
WO2000011140A1 (en) * 1998-08-20 2000-03-02 The Wistar Institute Of Anatomy And Biology Methods of augmenting mucosal immunity through systemic priming and mucosal boosting
JP4799789B2 (en) * 1999-08-25 2011-10-26 メルク・シャープ・エンド・ドーム・コーポレイション Synthetic human papillomavirus genes optimized for expression in human cells

Also Published As

Publication number Publication date
JP2004522789A (en) 2004-07-29
BR0207899A (en) 2004-10-19
WO2002070004A2 (en) 2002-09-12
WO2002070004A3 (en) 2003-12-31
GB0105606D0 (en) 2001-04-25
EP1399182A2 (en) 2004-03-24

Similar Documents

Publication Publication Date Title
AU2002336760A1 (en) Mutable vaccines
AU2002236159A1 (en) Immunogenic complex
AU2002254558A1 (en) Novel vaccine
AU2002359919A1 (en) Syringe
AU2003206862A1 (en) Hepatitis b vaccines
AU2002361092A1 (en) Syringe
AU2002322059A1 (en) Improved vaccination against anthrax
AU2003282498A1 (en) Hiv vaccine formulations
AU2003301850A1 (en) Hiv vaccine
AU2003285320A1 (en) Vaccine
AU5977700A (en) Vaccines
AU2002300685A1 (en) Mouth guard-preparing sheet
AU2002236065A1 (en) Papillomavirus vaccines
AU2002254161A1 (en) M cell directed vaccines
AU2002236160A1 (en) Immunogenic complex comprising ribosomes
AU2003237701A1 (en) Vaccines
AU2002304165A1 (en) Polynucleotide vaccine
AU2002222139A1 (en) Hcv vaccines
AU2001266534A1 (en) Papillomavirus vaccine
AU2002349142A1 (en) Syringe
GB0105238D0 (en) Vaccines
AU2002303093A1 (en) Mycobacterial vaccines
AU2002347346A1 (en) Dna vaccine
AU2002315309A1 (en) Vaccine against tuberculosis
AU2002355913A1 (en) Anti-tumor vaccines

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase